Suchergebnisse

570 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: 悪性の, bösartig, maligne, malignant

• 2021, Karanam NK, Story MD
  An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications [Grundlagen]
  Int J Radiat Biol 97 (8): 1044-1054
• 2021, Gentilal N, Salvador R, Miranda PC
  A Thermal Study of Tumor-Treating Fields for Glioblastoma Therapy [tech./dosim.]
  Brain and Human Body Modeling 2020. Springer, Cham (CH): S. 37-62; ISBN 978-3-030-45622-1
• 2021, Bomzon Z, Wenger C, Proescholdt M, Mohan S
  Tumor-Treating Fields at EMBC 2019: A Roadmap to Developing a Framework for TTFields Dosimetry and Treatment Planning [Grundlagen]
  Brain and Human Body Modeling 2020. Springer, Cham (CH): S. 3-17; ISBN 978-3-030-45622-1
• 2021, Dehghani-Soltani S, Eftekhar-Vaghefi SH, Babaee A, Basiri M, Mohammadipoor-Ghasemabad L, Vosough P, Ahmadi-Zeidabadi M
  Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O6-Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53 [med./bio.]
  Cancer Biother Radiopharm 36 (7): 579-587
• 2021, Aghajari S, Mortazavi SMJ, Kalani M, Nematolahi S, Habibzadeh P, Farjadian S
  The Immunomodulatory Effect of Radiofrequency Electromagnetic Field on Serum Cytokine Levels in A Mouse Model of Hindlimb Unloading [med./bio.]
  Cell J 22 (4): 401-405
• 2020, Sadeghi S, Madannejad A, Ravanbakhsh F, Ebrahimizadeh J, Perez MD, Augustine R
  A New Focused Hyperthermia Based on Space-Frequency DORT [tech./dosim.]
  2020 14th European Conference on Antennas and Propagation (EuCAP), Copenhagen, Denmark. IEEE: S. 1-3; ISBN 978-1-7281-3712-4
• 2020, Zhu Y, Fang Y, Yang J, Ji X, Fang Z, Shang P, Zhang X
  [Magnetic fields and angiogenesis] [fremdsprachig]
  Chin Sci Bull 65 (13): 1224-1237
• 2020, Shih YW, Hung CS, Huang CC, Chou KR, Niu SF, Chan S, Tsai HT
  The Association Between Smartphone Use and Breast Cancer Risk Among Taiwanese Women: A Case-Control Study [epidem.]
  Cancer Manag Res 12: 10799-10807
• 2020, Hossain S
  Biodielectric phenomenon for actively differentiating malignant and normal cells: An overview [Grundlagen]
  Electromagn Biol Med 39 (2): 89-96
• 2020, Kim JY, Jo Y, Oh HK, Kim EH
  Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3 [med./bio.]
  Am J Cancer Res 10 (10): 3475-3486
• 2020, Voloshin T, Schneiderman RS, Volodin A, Shamir RR, Kaynan N, Zeevi E, Koren L, Klein-Goldberg A, Paz R, Giladi M, Bomzon Z, Weinberg U, Palti Y
  Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics [med./bio.]
  Cancers 12 (10): E3016
• 2020, Lerchl A, Klose M, Drees (née Grote) K
  No Increased DNA Damage Observed in the Brain, Liver, and Lung of Fetal Mice Treated With Ethylnitrosourea and Exposed to UMTS Radiofrequency Electromagnetic Fields [med./bio.]
  Bioelectromagnetics 41 (8): 611-616
• 2020, Baskaran D, Arunachalam K
  Design of Site-Specific Microwave Phased Array Hyperthermia Applicators Using 434 MHz Reduced Cavity-Backed Patch Antenna [tech./dosim.]
  Bioelectromagnetics 41 (8): 630-648
• 2020, Zhao R, Liu Y, Liu S, Luo T, Zhong GY, Liu A, Zeng Q, Xin SX
  Apoptosis-Promoting Effects on A375 Human Melanoma Cells Induced by Exposure to 35.2-GHz Millimeter Wave [med./bio.]
  Technol Cancer Res Treat 19: 1533033820934131
• 2020, Hardell L, Carlberg M, Koppel T, Nordström M, Hedendahl LK
  Central nervous system lymphoma and radiofrequency radiation - A case report and incidence data in the Swedish Cancer Register on non-Hodgkin lymphoma [Grundlagen]
  Med Hypotheses 144: 110052
• 2020, Ghiaseddin AP, Shin D, Melnick K, Tran DD
  Tumor Treating Fields in the Management of Patients with Malignant Gliomas [Grundlagen]
  Curr Treat Options Oncol 21 (9): 76
• 2020, Ashta A, Motalleb G, Ahmadi-Zeidabadi M
  Evaluation of frequency magnetic field, static field, and Temozolomide on viability, free radical production and gene expression (p53) in the human glioblastoma cell line (A172) [med./bio.]
  Electromagn Biol Med 39 (4): 298-309
• 2020, Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M
  Management of glioblastoma: State of the art and future directions [Grundlagen]
  CA Cancer J Clin 70 (4): 299-312
• 2020, Xu A, Wang Q, Lin T
  Low-Frequency Magnetic Fields (LF-MFs) Inhibit Proliferation by Triggering Apoptosis and Altering Cell Cycle Distribution in Breast Cancer Cells [med./bio.]
  Int J Mol Sci 21 (8): E2952
• 2020, Chung TH, Stancampiano A, Sklias K, Gazeli K, André FM, Dozias S, Douat C, Pouvesle JM, Santos Sousa J, Robert É, Mir LM
  Cell Electropermeabilisation Enhancement by Non-Thermal-Plasma-Treated PBS [med./bio.]
  Cancers 12 (1): E219
• 2020, Kaufman D, Martinez M, Jauregui L, Ebbers E, Nuccitelli R, Knape WA, Uecker D, Mehregan D
  A dose-response study of a novel method of selective tissue modification of cellular structures in the skin with nanosecond pulsed electric fields [med./bio.]
  Lasers Surg Med 52 (4): 315-322
• 2019, Sprugnoli G, Monti L, Lippa L, Neri F, Mencarelli L, Ruffini G, Salvador R, Oliveri G, Batani B, Momi D, Cerase A, Pascual-Leone A, Rossi A, Rossi S, Santarnecchi E
  Reduction of intratumoral brain perfusion by noninvasive transcranial electrical stimulation [med. Anw.]
  Sci Adv 5 (8): eaau9309
• 2019, Soni VS, Yanagihara TK
  Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging [Grundlagen]
  Cancer Imaging 19 (1): 76
• 2019, Lin JC
  The Significance of Primary Tumors in the NTP Study of Chronic Rat Exposure to Cell Phone Radiation [Health Matters] [Kommentar]
  IEEE Microw Mag 20 (11): 18 - 21
• 2019, Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F
  Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial [med. Anw.]
  Lancet Oncol 20 (12): 1702-1709